FIRMAGON

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Mexico, Netherlands, Poland, Romania, Singapore, United Kingdom, South Africa

Active ingredients

The drug FIRMAGON contains one active pharmaceutical ingredient (API):

1 Degarelix
UNII I18S89P20R - DEGARELIX ACETATE

Degarelix is a selective gonadotrophin releasing-hormone (GnRH) antagonist that competitively and reversibly binds to the pituitary GnRH receptors, thereby rapidly reducing the release of the gonadotrophins, luteinizing hormone (LH) and follicle stimulating hormone (FSH), and thereby reducing the secretion of testosterone (T) by the testes.

Read about Degarelix

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
FIRMAGON Powder and solvent for solution for injection European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L02BX02 Degarelix L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02B Hormone antagonists and related agents → L02BX Other hormone antagonists and related agents
Discover more medicines within L02BX02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 2784M, 2785N
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 521416070006103, 521416070006203
Country: CA Health Products and Food Branch Identifier(s): 02337029, 02337037
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 4693-MEE-0419, 4791-MEE-0819
Country: EE Ravimiamet Identifier(s): 1400599, 1400601, 1500398
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 08504001, 08504002
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 040239, 040251
Country: FR Base de données publique des médicaments Identifier(s): 63329030, 69784330
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 165924, 165927, 368020, 374374, 376648, 380745, 381339
Country: HK Department of Health Drug Office Identifier(s): 61178, 61179
Country: IE Health Products Regulatory Authority Identifier(s): 88363, 88364, 89093
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 6672, 6673
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1036403, 1036404, 1058059
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 143M2009
Country: NL Z-Index G-Standaard, PRK Identifier(s): 90328
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100102795, 100149220
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W54154001, W54155001
Country: SG Health Sciences Authority Identifier(s): 14350P, 14351P
Country: ZA Health Products Regulatory Authority Identifier(s): 43/21.12/0918, 43/21.12/0920

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.